@chescaleigh As an aside to this, I listened to an Ear Biscuits episode about friendship and Link kinda made the point that if you have difficulty being the initiator, at least be an eager participant. Show up, be present, put in the effort to be game for whatever the plan is (within reason).
!!!!!!!!!!!!! @JNJNews, THANK YOU for choosing #PatientsNotPatents. Takes real guts to live up to your credo. Generic bedaquiline WILL BE AVAILABLE in almost every country with a high tuberculosis burden. I am so happy and grateful to the Stop TB Partnership, J&J, and especially the activists around the world who are standing up for TB patients. So much more work to do, but WHAT WONDERFUL NEWS TO WAKE UP TO.
J&J are attempting to extend their patent on a life-saving drug that can potentially save millions of lives around the world instead of letting the patent end and making the drug more affordable for way more people. And they are hiding from the outcry by turning off replies lmao.
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: https://t.co/6m49h5g7tn
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
I want to be very clear that no one is SUGGESTING that people will die because Johnson & Johnson is trying to immorally extend their patent on bedaquline an additional 4 years after its 20-year term.
Instead, people are STATING THE FACT that people will die because of Johnson & Johnson trying to immorally extend their patent on bedaquiline an additional 4 years after its 20-year term.
Story J Company welcomes #KangMina to the family and shares how they will support her future activities as actress. Kang joins home of her #CafeMinamdang's co-stars Seo Inguk, Oh Yeonseo, Kwon Soohyun
https://t.co/srqKexdK2P #KoreanUpdates RZ
@paolovalenciano Network wars were manufactured for the boomers anyway dahil uso pa yung "channel loyalty" noon. Things are different now and it's about time they adjusted.
@pissinurcereal @Boom___Shaka@cursinyourname My reply honestly has nothing to do with the original tweet lol I was just replying to the person asking why being a nepo baby is considered a "bad thing".
Nobody is trying to "cancel" nepo babies, they just want to point out that it's a factor to success.